New hope for systemic sclerosis patients with digital ulcers.
Varga
John
J
D000284:Administration, Oral; D000077300:Bosentan; D056486:Chemical and Drug Induced Liver Injury; D004311:Double-Blind Method; D065128:Endothelin Receptor Antagonists; D005385:Fingers; D005533:Foot Dermatoses / Q000517:prevention & control*; D006229:Hand Dermatoses / Q000517:prevention & control*; D006801:Humans; D012594:Scleroderma, Localized / Q000188:drug therapy; D012595:Scleroderma, Systemic / Q000150:complications / Q000188:drug therapy*; D012883:Skin Ulcer / Q000517:prevention & control*; D013449:Sulfonamides / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D014034:Toes; D016896:Treatment Outcome
D065128:Endothelin Receptor Antagonists; D013449:Sulfonamides; D000077300:Bosentan